A detailed history of Asset Management One Co., Ltd. transactions in Veracyte, Inc. stock. As of the latest transaction made, Asset Management One Co., Ltd. holds 4,943 shares of VCYT stock, worth $203,552. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,943
Previous 7,018 29.57%
Holding current value
$203,552
Previous $152,000 10.53%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$21.0 - $35.25 $43,575 - $73,143
-2,075 Reduced 29.57%
4,943 $168,000
Q2 2024

Jul 18, 2024

BUY
$18.86 - $23.55 $46,414 - $57,956
2,461 Added 54.0%
7,018 $152,000
Q1 2024

May 02, 2024

BUY
$21.0 - $29.1 $47,124 - $65,300
2,244 Added 97.02%
4,557 $100,000
Q4 2023

Jan 24, 2024

SELL
$19.72 - $28.68 $28,594 - $41,586
-1,450 Reduced 38.53%
2,313 $63,000
Q3 2023

Oct 19, 2023

BUY
$22.33 - $29.92 $84,027 - $112,588
3,763 New
3,763 $84,000

Others Institutions Holding VCYT

About VERACYTE, INC.


  • Ticker VCYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,575,904
  • Market Cap $2.95B
  • Description
  • Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...
More about VCYT
Track This Portfolio

Track Asset Management One Co., Ltd. Portfolio

Follow Asset Management One Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Asset Management One Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Asset Management One Co., Ltd. with notifications on news.